Saturday, October 16, 2021

Comments by Christopher Lane, PhD

Showing 6 of 6 comments.

  • Thank you, Exit. I agree. I wanted in this and recent posts to document a decades’ long, profession-wide *effort at* denying the existence of antidepressant withdrawal, including to emphasize that the effort *has* failed, importantly because of years of pushback and documented evidence. I wanted readers to see for themselves how even letters published *in the psychiatric journals* themselves failed to make a lasting impact at the time—that’s part of the longer history and I’d say it’s crucial that it be recorded as well as reintroduced into discussions today, precisely to ask: How *is* it that so many in the profession managed to turn a blind eye and a deaf ear to something so serious and so widespread?

  • Thanks for your comment, Sam. Yes, regrettably, “psychosis” almost always is invoked as a validating foundation, even (or especially) when it is not. Of particular interest to me there is that DSM-II in 1968 began the process of deleting earlier references to psychical states as “reactions” and turned them instead into “disorders,” a move consolidated by DSM-III (1980), so we lost situational and social-environmental stressors almost at the stroke of a pen. That’s also one explanation, incidentally, for how the “biological model” and ontologized brain states became predominant, particularly in the U.S. in those decades and really ever since.

  • Yes, and thanks for your comment. I wanted this put in — hopefully with a clear irony light attached to those quote marks — because, unfortunately, it’s still quite common to hear psychotherapists and psychoanalytically-oriented psychiatrists talk of SSRIs (and psychiatric drugs more generally) as somehow “kickstarting” the therapy and “accelerating” it through a combination treatment. The notion remains widespread despite, as you note, the mounting evidence of serious adverse effects and withdrawal syndrome from the drugs themselves, which obviously would impede a productive therapy and should be increasing caution, but that doesn’t appear to be getting through to many prescribers. Worrying and frustrating.